Search
Search
About
Log in
Join
Experiences with
Simeprevir
Posts
Communities
11 public posts
Filter results
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
However, the pairing is the same price as the combination of Sovaldi and Janssen’s Olysio (
simeprevir
), which is approved to treat genotype 1.
However, the pairing is the same price as the combination of Sovaldi and Janssen’s Olysio (
simeprevir
), which is approved to treat genotype 1.
kcohen
in
HFI Connect - Hepatitis
9 years ago
WHO Adds New Hepatitis C Drugs to Essential Medicines List
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as
simeprevir
(Olysio), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as
simeprevir
(Olysio), daclatasvir, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (
simeprevir
), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (
simeprevir
), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Harvoni and Sovaldi/Daclatasvir Safer to Mix With HIV Meds
The investigators determined the potential drug-drug interactions (DDIs) between each individual’s HIV regimen and four hep C regimens: Janssen’s Olysio (
simeprevir
) and Sovaldi; AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir); Harvoni; and Sovaldi and daclatasvir.
The investigators determined the potential drug-drug interactions (DDIs) between each individual’s HIV regimen and four hep C regimens: Janssen’s Olysio (
simeprevir
) and Sovaldi; AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir); Harvoni; and Sovaldi and daclatasvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (
simeprevir
), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (
simeprevir
), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Olysio-Sovaldi Combo Cures High Rates of Hep C Genotype 1
Twelve weeks of Janssen’s Olysio (
simeprevir
) and Gilead Sciences’ Sovaldi (sofosbuvir) boasted near-perfect cure results in a recent trial treating people with genotype 1 of hepatitis C virus (HCV) who did not have cirrhosis.
Twelve weeks of Janssen’s Olysio (
simeprevir
) and Gilead Sciences’ Sovaldi (sofosbuvir) boasted near-perfect cure results in a recent trial treating people with genotype 1 of hepatitis C virus (HCV) who did not have cirrhosis.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck’s Hep C Meds Work Well in Treatment-Experienced People
The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon, ribavirin and either Olysio (
simeprevir
), Incivek (telaprevir) or Victrelis (boceprevir). Results were presented at the 50th International Liver Congress in Vienna, Austria.
The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon, ribavirin and either Olysio (
simeprevir
), Incivek (telaprevir) or Victrelis (boceprevir). Results were presented at the 50th International Liver Congress in Vienna, Austria.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Options for Treating Hepatitis C in Those With Advanced Cirrhosis
Various combinations of Sovaldi (sofosbuvir), Olysio (
simeprevir
) and ribavirin have shown moderate promise in curing people with genotype 1 or 2 of hepatitis C virus (HCV) who have decompensated cirrhosis.
Various combinations of Sovaldi (sofosbuvir), Olysio (
simeprevir
) and ribavirin have shown moderate promise in curing people with genotype 1 or 2 of hepatitis C virus (HCV) who have decompensated cirrhosis.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Raising Hope for Those Living With HepatitisC
New treatment options, including two drugs (sofosbuvir and
simeprevir
) recently approved by the Federal Drug Administration, offer hope to those living with hepatitis C. Read more here: http://huff.to/18RnZUp
New treatment options, including two drugs (sofosbuvir and
simeprevir
) recently approved by the Federal Drug Administration, offer hope to those living with hepatitis C. Read more here: http://huff.to/18RnZUp
mwright
in
HFI Connect - Hepatitis
10 years ago
FDA approves simeprevir treatment for Hep C
The US FDA has announced its formal approval of
simeprevir
as a treatment for hepatitis C. Read more on the developments here: http://buff.ly/1hdFvtX
The US FDA has announced its formal approval of
simeprevir
as a treatment for hepatitis C. Read more on the developments here: http://buff.ly/1hdFvtX
Hep_C_News_team
in
Hepatitis C Trust
11 years ago
New Hepatitis C Drug SIMEPREVIR being reviewed in Canada-needs patient input
New drug being reviewed:
simeprevir
(similar to boceprevir and telaprevir, but only one pill per day and does not require special food intake). Deadline: midnight, Sept. 11, 2013. Give input at: http://hepcbc.ca/2013/08/urgent-request-for-your-input-into-a-new-hcv-drug-
simeprevir
/ . THANKS!
New drug being reviewed:
simeprevir
(similar to boceprevir and telaprevir, but only one pill per day and does not require special food intake). Deadline: midnight, Sept. 11, 2013. Give input at: http://hepcbc.ca/2013/08/urgent-request-for-your-input-into-a-new-hcv-drug-
simeprevir
/ . THANKS!
Cheryl-HepCBC
HepCBC
in
HepCBC Hepatitis C Education & Prevention Society
11 years ago
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
9 results
Hepatitis C Trust
1 result
HepCBC Hepatitis C Education & Prevention Society
1 result
Sort by
Most Relevant
Newest